Hereditary Testing Market, Report Disease Type, By Technology, End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

The Hereditary Testing Market size was valued at US$16,110.20 Million in 2024, expanding at a CAGR of 14.01% from 2025 to 2032.

The global hereditary testing market is witnessing significant growth due to the rising prevalence of genetic disorders, increased public awareness, and advancements in testing technologies. Hereditary testing plays an essential role in assessing genetic risks and is widely utilized for prenatal screening, cancer susceptibility testing, and carrier screening. The integration of next-generation sequencing technologies and the expansion of access to genetic testing services are key factors driving market growth across both developed and emerging regions.

Hereditary Testing Market- Market Dynamics

Rising prevalence of genetic disorders

The rising prevalence of hereditary conditions such as cystic fibrosis, sickle cell disease, and various inherited cancers is a key driver of the hereditary testing market, as regular genetic screening and monitoring are essential for effective disease management, risk assessment, and patient counselling. Advancements in multi-gene panel testing have significantly improved diagnostic accuracy, efficiency, and clinical relevance, supporting broader adoption in routine care. Growing awareness among healthcare professionals and patients about the role of genetic testing in personalised medicine is further accelerating demand. For instance, in November 2024, CeGaT GmbH launched the enhanced ExomeXtra v6 exome enrichment product, offering expanded coverage of non-coding splice regions and copy number variations (CNVs) to enable more precise diagnostics for hereditary conditions, including tumour syndromes. Additionally, continuous innovations in laboratory automation, digital health platforms, and telemedicine are improving accessibility and turnaround times, reinforcing sustained market growth and technological advancement.

Hereditary Testing Market- Segmentation Analysis:

The Global Hereditary Testing Market is segmented based on Disease Type, Technology, End User, and Region.

Based on Disease Type, the market is segmented into Cystic Fibrosis, Sickle Cell Disease, Hemophilia, and Other Genetic Disorders. Cystic fibrosis and sickle cell disease testing account for significant shares due to their high prevalence and the increasing demand for early diagnosis and management. The availability of established screening programs and growing awareness of inherited disorders further support market growth. Additionally, early intervention strategies and newborn screening initiatives contribute to higher testing rates.

Based on Technology, the market is categorised into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Others. Next-generation sequencing dominates this segment, driven by advancements that offer high accuracy and efficiency in genetic testing. Its ability to analyse multiple genes simultaneously reduces turnaround time and cost per test. Expanding clinical applications and declining sequencing costs further strengthen NGS adoption.

Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, Genetic Testing Centres, and Others. Hospitals and diagnostic laboratories hold the largest share, as they facilitate high volumes of testing and support patient management through comprehensive genetic services. The presence of multidisciplinary care teams and advanced diagnostic infrastructure enhances their role in genetic disease diagnosis and monitoring.

Hereditary Testing Market- Geographical Insights

North America leads the hereditary testing market, driven by its advanced healthcare infrastructure and high adoption rates of genetic testing. This region benefits from ongoing research initiatives and favourable reimbursement policies. Europe follows closely, supported by strong public health systems and increasing awareness of genetic disorders. The Asia-Pacific region is expected to experience the fastest growth, fueled by rising healthcare expenditures, increased public awareness, and developments in genetic testing technology. Countries in Latin America and the Middle East & Africa are displaying steady growth due to gradual improvements in healthcare access and growing demand for genetic testing services.

Hereditary Testing Market- Country Insights

The United States holds a dominant position in the hereditary testing market, primarily due to high testing volumes, advanced diagnostics, and the presence of leading genetic testing companies. In Europe, countries like Germany, the UK, and France significantly contribute to market growth, supported by well-established healthcare systems promoting regular genetic testing. In Asia, China and India are rapidly emerging as high-growth markets, driven by large populations, increasing awareness of genetic health issues, and expanding healthcare infrastructure. This landscape enhances the accessibility and availability of hereditary testing solutions, driving overall market demand.

Hereditary Testing Market- Competitive Landscape:

The hereditary testing market is moderately competitive, featuring key players such as Illumina, Thermo Fisher Scientific, Quest Diagnostics, Invitae Corporation, Agilent Technologies, Myriad Genetics, GeneDx, Fulgent Genetics, ArcherDX, and BGI Group. These companies focus on assay innovation, automation, and expanding their test portfolios to meet growing healthcare demands. Significant investments in next-generation sequencing technologies, streamlined workflows, and integrated solutions are enhancing accuracy and efficiency. Strategic partnerships and geographic expansion are key strategies that enable participants to strengthen their market positions in response to the increasing demand for hereditary testing services, for instance, February 2025: Fulgent Genetics, Inc. partnered with Foundation Medicine, Inc. to introduce two hereditary germline tests FoundationOne Germline and FoundationOne Germline More in the U.S., leveraging Fulgent's advanced technology platform to enhance comprehensive genetic testing capabilities.

Recent Developments:

In November 2024, CeGaT GmbH launched version 6 (v6) of its proprietary ExomeXtra exome enrichment product, enhancing coverage of non-coding splice regions and copy number variations (CNVs). This upgrade supports improved diagnostic accuracy, particularly for hereditary tumour syndromes, by enabling the detection of a broader spectrum of genetic alterations, including rare and complex variants that were previously challenging to identify.

In October 2023 a rural hospital system in North Carolina, in collaboration with Invitae, implemented universal hereditary testing for all breast cancer patients. The initiative achieved a 91.4% testing uptake and identified pathogenic germline variants in 13% of tested patients, leading to changes in clinical management for nearly 70% of cases. This program highlights the effectiveness of integrating hereditary testing into diverse healthcare settings, enhancing patient outcomes while optimising the use of healthcare resources.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEREDITARY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Illumina
Thermo Fisher Scientific
Quest Diagnostics
Invitae Corporation
Agilent Technologies
Myriad Genetics
GeneDx
Fulgent Genetics
Archerdx
BGI Group
Others

GLOBAL HEREDITARY TESTING MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

Cystic Fibrosis
Sickle Cell Disease
Hemophilia
Others

GLOBAL HEREDITARY TESTING MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032

Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Others

GLOBAL HEREDITARY TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic Laboratories
Genetic Testing Centers
Others

GLOBAL HEREDITARY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5962

1. Hereditary Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Hereditary Testing Market Snippet by Disease Type
- 2.1.2. Hereditary Testing Market Snippet by Technology
- 2.1.3. Hereditary Testing Market Snippet by End User
- 2.1.4. Hereditary Testing Market Snippet by Country
- 2.1.5. Hereditary Testing Market Snippet by Region
2.2. Competitive Insights

3. Hereditary Testing Key Market Trends

3.1. Hereditary Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Hereditary Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Hereditary Testing Market Opportunities
3.4. Hereditary Testing Market Future Trends

4. Hereditary Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Hereditary Testing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Hereditary Testing Market Landscape

6.1. Hereditary Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Hereditary Testing Market - By Disease Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Disease Type, 2024&2032 (%)
- 7.1.2. Cystic Fibrosis
- 7.1.3. Sickle Cell Disease
- 7.1.4. Hemophilia
- 7.1.5. Others

8. Hereditary Testing Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
- 8.1.2. Next-Generation Sequencing (NGS)
- 8.1.3. Polymerase Chain Reaction (PCR)
- 8.1.4. Microarray
- 8.1.5. Others

9. Hereditary Testing Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Diagnostic Laboratories
- 9.1.4. Genetic Testing Centers
- 9.1.5. Others

10. Hereditary Testing Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Hereditary Testing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
- 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Hereditary Testing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
- 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.8.3. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.9.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.10.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.11.3. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.14.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.15.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Hereditary Testing Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.4.4. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
- 10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.7.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.8.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.14.3. PhilippinesMarket Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Hereditary Testing Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.5.4. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
- 10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Hereditary Testing Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 10.6.4. MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
- 10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.8.3. UAE Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Hereditary Testing Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Illumina
- 11.2.2. Thermo Fisher Scientific
- 11.2.3. Quest Diagnostics
- 11.2.4. Invitae Corporation
- 11.2.5. Agilent Technologies
- 11.2.6. Myriad Genetics
- 11.2.7. GeneDx
- 11.2.8. Fulgent Genetics
- 11.2.9. Archerdx
- 11.2.10. BGI Group
- 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us